ER+/HER2- BREAST CANCER
Clinical trials for ER+/HER2- BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ER+/HER2- BREAST CANCER trials appear
Sign up with your email to follow new studies for ER+/HER2- BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
DNA vaccine aims to train body to fight breast cancer
⭐️ VACCINE ⭐️ OngoingThis early-stage study tests whether a DNA vaccine that targets a protein called mammaglobin-A (found on many breast cancer cells) is safe for people with ER+, HER2- breast cancer. The vaccine is given alongside standard hormone therapy or chemotherapy before surgery. The study i…
Matched conditions: ER+/HER2- BREAST CANCER
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
New oral drug aims to tackle Hormone-Driven cancers
Disease control OngoingThis study tests an experimental drug, imlunestrant, in people with advanced or metastatic breast cancer that is estrogen-receptor positive (ER+), as well as certain other cancers like endometrial cancer. The drug is given alone or combined with other anticancer therapies. The ma…
Matched conditions: ER+/HER2- BREAST CANCER
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC